Mikra Reports Further Clinical Research that Validates Category-Defining Formulation of CELLF Cellular Health Supplement

PRESSBEE - Latest updates
Mikra Reports Further Clinical Research that Validates Category-Defining Formulation of CELLF Cellular Health Supplement
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to transform human wellness, is pleased to report, on behalf of its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") that independent and rigorous clinical research studies recently published by esteemed universities confirm the importance of the key ingredients in the category-defining formulation of Mikra's CELLF cellular health supplement. “We are gratified to see the publication of ongoing clinical research that validates our vision for CELLF as a n

Apple Storegoogle play

Last updated :

Also on site :

    Most viewed in Latest updates


    Latest News